Stock ENLV ENLIVEX THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Enlivex Therapeutics Ltd.

Equities

ENLV

IL0011319527

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
1.44 USD -0.69% Intraday chart for Enlivex Therapeutics Ltd. +9.09% -46.67%
04-22 Enlivex Therapeutics Says First Two Patients Dosed in Knee Osteoarthritis Trial MT
04-16 Enlivex Therapeutics Receives Approval to Expand Trial of Allocetra to Treat Knee Osteoarthritis Into Denmark MT

Chart calendar Enlivex Therapeutics Ltd.

e.oMg6ijJxdmLPTN_syklAtNQGMJ104llUrEDHKadRkVY.9b8Py3ohHzCLGJHZkgQRhLF_Be4xpxwn2iL-HtBg-RnCv2v5QCUOC70-uA~9f41b7837640e80f9cda71696177243a

Upcoming events on Enlivex Therapeutics Ltd.

2024-05-23 Q1 2024 Earnings Release (Projected)
2025-05-22 Q1 2025 Earnings Release (Projected)

Past events on Enlivex Therapeutics Ltd.

2024-04-12 08:30 Allocetra Phase II Trial Results Call
2024-03-20 RedChip Investor Group Call
2023-09-12 17:00 H.C. Wainwright Global Investment Conference
2023-06-26 08:00 Q1 2023 Earnings Release
2023-06-09 11:30 Jefferies Global Healthcare Conference
2023-06-01 12:00 International Society for Cell & Gene Therapy Meeting - Poster No:1057
2023-06-01 12:00 International Society for Cell & Gene Therapy Meeting - Poster No:1003
2023-05-31 13:00 International Society for Cell & Gene Therapy Meeting - Poster No:805
2022-12-05 08:00 Q3 2022 Earnings Release
2022-11-09 Society for Immunotherapy of Cancer Meeting
2022-10-06 14:30 Macrophage directed Therapies Summit
2022-09-15 09:20 Cantor Cell and Genetic Medicines Conference - Panel
2022-09-14 15:10 Baird Global Healthcare Conference
2022-09-13 11:00 H.C. Wainwright Global Investment Conference
2022-09-11 European Society for Medical Oncology
2022-08-22 08:00 Interim 2022 Earnings Release
2022-06-09 13:00 Jefferies Healthcare Conference
2022-06-05 09:00 American Society of Clinical Oncology Meeting
2022-05-22 H.C. Wainwright Global Investment Conference - Pre-Recorded
2022-04-29 08:41 FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-8,62
-8,08
-6.67%		-9,79
-8,79
-11.35%		-19,3
-17,0
-13.73%		-25,8
-24,0
-7.7%		-29,4
-23,8
-23.72%
-16,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-14,5
-15,6
7.04%		-31,1
-30,9
-0.61%		-29,1
-25,2
-15.47%
-16,3

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-14,5
-15,6
7.04%		-31,1
-30,9
-0.61%		-29,1
-25,2
-15.47%
-16,3

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-0,81
-0,86
5.81%		-1,69
-1,68
-0.6%		-1,56
-1,36
-14.71%
-0,86

Announcement Date30/04/2030/04/2129/04/2231/03/2329/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00




EBIT
Million USD		Released
Forecast
Spread 		-7,81
-4,85
-61.11%		-6,40
-8,10
20.94%		-5,87
-7,70
23.75%		-5,68
-5,30
-7.11%		-7,85
-6,00
-30.75%		-6,78
-7,30
7.08%		-6,65
-7,00
5.01%		-5,63
-6,00
6.2%		-10,3
-4,70
-119.89%
-4,60


-4,40


-3,80


-3,50




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,74
-5,31
10.81%		-8,23
-7,59
-8.44%		-9,91
-8,20
-20.89%		-5,73
-5,31
-8.05%		-7,19
-7,00
-2.7%		-7,22
-7,31
1.19%		-6,79
-8,00
15.1%		-5,96
-6,01
0.72%		-9,10
-5,20
-74.9%
-4,60


-4,40


-3,80


-3,50




Net income
Million USD		Released
Forecast
Spread 		-4,74
-5,31
10.81%		-8,23
-7,59
-8.44%		-9,91
-8,20
-20.89%		-5,73
-5,31
-8.05%		-7,19
-7,00
-2.7%		-7,22
-7,31
1.19%		-6,79
-8,00
15.1%		-5,96
-6,01
0.72%		-9,10
-5,20
-74.9%
-4,60


-4,40


-3,80


-3,50




EPS
USD		Released
Forecast
Spread 		-0,26
-0,28
7.14%		-0,45
-0,41
-9.76%		-0,54
-0,45
-20%		-0,31
-0,29
-6.9%		-0,39
-0,38
-2.63%		-0,39
-0,40
2.5%		-0,37
-0,43
13.95%		-0,32
-0,32
0%		-0,48
-0,28
-71.43%
-0,25


-0,24


-0,20


-0,17


-0,14

Announcement Date29/04/2227/05/2222/08/2202/12/2231/03/2316/06/2301/09/2309/11/2329/03/24-----

Upcoming sector events for Enlivex Therapeutics Ltd.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 16:05 EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Enlivex Therapeutics Ltd.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 16:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Calendar Enlivex Therapeutics Ltd.